PortfoliosLab logoPortfoliosLab logo
BMY vs. TIMB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BMY vs. TIMB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bristol-Myers Squibb Company (BMY) and TIM S.A. (TIMB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BMY achieves a 8.27% return, which is significantly lower than TIMB's 15.30% return.


BMY

1D
0.40%
1M
0.23%
YTD
8.27%
6M
11.43%
1Y
20.57%
3Y*
0.45%
5Y*
0.73%
10Y*
1.00%

TIMB

1D
0.54%
1M
1.69%
YTD
15.30%
6M
11.44%
1Y
31.26%
3Y*
22.01%
5Y*
19.21%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BMY vs. TIMB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
BMY
Bristol-Myers Squibb Company
8.27%0.11%15.81%-26.14%18.98%2.88%3.48%
TIMB
TIM S.A.
15.30%86.96%-33.24%68.57%4.05%-13.46%23.03%

Correlation

The correlation between BMY and TIMB is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Oct 16, 2020

0.13

Fundamentals

Market Cap

BMY:

$116.75B

TIMB:

$10.65B

EPS

BMY:

$3.57

TIMB:

R$9.00

PE Ratio

BMY:

16.02

TIMB:

12.63

PEG Ratio

BMY:

0.91

TIMB:

0.76

PS Ratio

BMY:

2.40

TIMB:

2.02

PB Ratio

BMY:

5.82

TIMB:

2.22

Total Revenue (TTM)

BMY:

$48.48B

TIMB:

R$27.04B

Gross Profit (TTM)

BMY:

$33.33B

TIMB:

R$14.61B

EBITDA (TTM)

BMY:

$13.34B

TIMB:

R$13.92B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BMY vs. TIMB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMY
BMY Risk / Return Rank: 6565
Overall Rank
BMY Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
BMY Sortino Ratio Rank: 6161
Sortino Ratio Rank
BMY Omega Ratio Rank: 5858
Omega Ratio Rank
BMY Calmar Ratio Rank: 7171
Calmar Ratio Rank
BMY Martin Ratio Rank: 7070
Martin Ratio Rank

TIMB
TIMB Risk / Return Rank: 6868
Overall Rank
TIMB Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
TIMB Sortino Ratio Rank: 6565
Sortino Ratio Rank
TIMB Omega Ratio Rank: 6464
Omega Ratio Rank
TIMB Calmar Ratio Rank: 6767
Calmar Ratio Rank
TIMB Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMY vs. TIMB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and TIM S.A. (TIMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BMYTIMBDifference
Sharpe ratioReturn per unit of total volatility

-0.25

Sortino ratioReturn per unit of downside risk

-0.23

Omega ratioGain probability vs. loss probability

1.14

1.17

-0.04

Calmar ratioReturn relative to maximum drawdown

1.53

1.22

+0.30

Martin ratioReturn relative to average drawdown

3.32

3.35

-0.03

BMY vs. TIMB - Sharpe Ratio Comparison

The current BMY Sharpe Ratio is 0.68, which is comparable to the TIMB Sharpe Ratio of 0.93. The chart below compares the historical Sharpe Ratios of BMY and TIMB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BMY vs. TIMB - Drawdown Comparison

The maximum BMY drawdown since its inception was -72.03%, which is greater than TIMB's maximum drawdown of -37.08%. Use the drawdown chart below to compare losses from any high point for BMY and TIMB.


Loading charts...

Drawdown Indicators


BMYTIMBDifference

Max Drawdown

Largest peak-to-trough decline

-72.03%

-37.08%

-34.95%

Max Drawdown (1Y)

Largest decline over 1 year

-12.05%

-23.82%

+11.77%

Max Drawdown (3Y)

Largest decline over 3 years

-36.85%

-37.08%

+0.23%

Max Drawdown (5Y)

Largest decline over 5 years

-47.67%

-37.08%

-10.59%

Max Drawdown (10Y)

Largest decline over 10 years

-47.67%

Current Drawdown

Current decline from peak

-17.79%

-20.28%

+2.49%

Average Drawdown

Average peak-to-trough decline

-22.38%

-12.14%

-10.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.34%

8.68%

-2.34%

Volatility

BMY vs. TIMB - Volatility Comparison

Bristol-Myers Squibb Company (BMY) has a higher volatility of 8.22% compared to TIM S.A. (TIMB) at 6.33%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than TIMB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BMYTIMBDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.22%

6.33%

+1.89%

Volatility (6M)

Calculated over the trailing 6-month period

18.18%

25.37%

-7.19%

Volatility (1Y)

Calculated over the trailing 1-year period

27.08%

31.42%

-4.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.02%

31.55%

-7.53%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.29%

32.10%

-6.81%

Dividends

BMY vs. TIMB - Dividend Comparison

BMY's dividend yield for the trailing twelve months is around 4.38%, less than TIMB's 8.17% yield.


PositionTTM20252024202320222021202020192018201720162015
BMY
Bristol-Myers Squibb Company
4.38%4.60%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%
TIMB
TIM S.A.
8.17%11.67%6.03%4.98%4.05%3.43%3.05%0.00%0.00%0.00%0.00%0.00%

Financials

BMY vs. TIMB - Financials Comparison

This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and TIM S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


4.00B6.00B8.00B10.00B12.00B20222023202420252026
11.49B
6.81B
(BMY) Total Revenue
(TIMB) Total Revenue
Please note, different currencies. BMY values in USD, TIMB values in BRL

BMY vs. TIMB - Profitability Comparison

The chart below illustrates the profitability comparison between Bristol-Myers Squibb Company and TIM S.A. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%20222023202420252026
70.2%
52.4%
Portfolio components
BMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.

TIMB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TIM S.A. reported a gross profit of 3.56B and revenue of 6.81B. Therefore, the gross margin over that period was 52.4%.

BMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.

TIMB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TIM S.A. reported an operating income of 1.57B and revenue of 6.81B, resulting in an operating margin of 23.1%.

BMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.

TIMB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TIM S.A. reported a net income of 817.09M and revenue of 6.81B, resulting in a net margin of 12.0%.


Frequently Asked Questions


BMY and TIMB have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BMY has higher volatility (8.22%) compared to TIMB (6.33%). In terms of maximum drawdown, BMY dropped -72.03% vs TIMB's -37.08%.

TIMB currently has the higher Sharpe Ratio (0.93 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BMY and TIMB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer